All articles by Divya Tirumalaraju

  1. MediciNova to study ibudilast for Covid-19-related ARDS

    Biopharmaceutical company MediciNova has plans to study its investigational drug, ibudilast (MN-166), to treat acute respiratory distress syndrome (ARDS) associated…
    Read More…

    9 Apr
  2. Novavax to commence human trial for Covid-19 vaccine

    Biotechnology firm Novavax is set to start the human clinical trial of a Covid-19 vaccine candidate called NVX-CoV2373 in May….
    Read More…

    9 Apr
  3. OncoImmune gets approval to trial CD24Fc for Covid-19 in US

    The US Food and Drug Administration (FDA) has granted approval for OncoImmune to conduct a Phase III clinical trial of…
    Read More…

    9 Apr
  4. Zelira Therapeutics’ cannabis trial meets goals for insomnia

    Zelira Therapeutics has reported positive data from the Phase Ia/IIb clinical trial of medicinal cannabis for the treatment of insomnia….
    Read More…

    8 Apr
  5. Covid-19: IQVIA launches registry and trial matching tool

    Life sciences services provider IQVIA has introduced an open Covid-19 registry platform and technology-powered trial matching solution. The registry, referred…
    Read More…

    8 Apr
  6. Queen’s University Belfast trials cell therapy for coronavirus

    Queen’s University Belfast researchers are conducting a clinical trial of a cell therapy to treat acute respiratory distress syndrome (ARDS)…
    Read More…

    8 Apr
  7. Immunomedics stops Phase III breast cancer study early

    Biopharmaceutical company Immunomedics has stopped the confirmatory Phase III ASCENT clinical trial of sacituzumab govitecan early after obtaining encouraging efficacy…
    Read More…

    7 Apr
  8. Lancaster University reports positive data for HIV drugs in Covid-19

    A statistician at Lancaster University in the UK has revealed positive results from a randomised clinical trial conducted in China…
    Read More…

    7 Apr
  9. Inovio commences Phase I trial of DNA vaccine for Covid-19

    Inovio Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for the investigational new drug (IND) application…
    Read More…

    7 Apr
  10. Covid-19 delays enrolment for resTORbio’s Parkinson’s trial

    resTORbio has put enrolment for the fifth cohort of RTB101’s Phase Ib/IIa Parkinson’s disease (PD) trial on hold amid the…
    Read More…

    6 Apr
Close
Close
Close

Go Top